Pharmacoeconomic analysis of conservative strategy for the treatment of patients with diabetic foot syndrome in Moscow

Aim. To perform cost-effectiveness analysis of prescription of pharmaceutical products and dressing materials and their consumption volume for inandout-patient treatment of diabetic foot syndrome (DFS). To analyse efficacy of the treatment in terms of modern therapeutic standards. Materials and met...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Marina Fedorovna Kalashnikova, Nadezhda Viktorovna Maksimova, Ivan Ivanovich Dedov
Formato:	article
Lenguaje:	EN RU
Publicado:	Endocrinology Research Centre 2011
Materias:	diabetic foot syndrome pharmacoeconomic analysis modern therapeutic standards pentoxifylline Nutritional diseases. Deficiency diseases RC620-627
Acceso en línea:	https://doaj.org/article/16c8a85b71f9412a80940ad61ddf61fd
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:16c8a85b71f9412a80940ad61ddf61fd
record_format	dspace
spelling	oai:doaj.org-article:16c8a85b71f9412a80940ad61ddf61fd2021-11-14T09:00:16ZPharmacoeconomic analysis of conservative strategy for the treatment of patients with diabetic foot syndrome in Moscow2072-03512072-037810.14341/2072-0351-6233https://doaj.org/article/16c8a85b71f9412a80940ad61ddf61fd2011-09-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/6233https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378Aim. To perform cost-effectiveness analysis of prescription of pharmaceutical products and dressing materials and their consumption volume for inandout-patient treatment of diabetic foot syndrome (DFS). To analyse efficacy of the treatment in terms of modern therapeutic standards. Materials and methods. This retrospective study is based on the medical documentation of 139 DM1 and DM2 patients with DFS from differentmedical facilities of Moscow (2007). 72 patients were given general out-patient care by surgeons of city polyclinics, 50 ones received specialized aidin the regional Diabetic Foot Cabinet. 67 patients were hospitalized: 20 for general care in the department of purulent surgery of a military hospital,27 for specialized care in the department of purulent surgery of a city hospital, 20 for high-technology care in the endocrinological clinic of the FirstMoscow State Medical University. Results. Therapeutic strategy for DFS patients used in the regional Diabetic Foot Cabinet met the current therapeutic standards. General out-patientcare by surgeons of city polyclinics was at variance with the algorithms adopted in this country. Pharmacoeconomic analysis of the spectrum of pharmaceuticalproducts used for in- and out-patient treatment of DFS patients revealed frequent and ungrounded application of drugs whose woundhealing effect remains to be confirmed (pentoxifylline, thioctoic and alpha-lipoic acids). Conclusion. Additional training courses for surgeons of Moscow polyclinics are needed to improve the quality of medical aid to DFS patients. Suchpatients must be referred to regional Diabetic Foot Cabinets. Pentoxifylline, thioctoic and alpha-lipoic acids need to be substituted by pharmaceuticalswith validated therapeutic efficacy.Marina Fedorovna KalashnikovaNadezhda Viktorovna MaksimovaIvan Ivanovich DedovEndocrinology Research Centrearticlediabetic foot syndromepharmacoeconomic analysismodern therapeutic standardspentoxifyllineNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 14, Iss 3, Pp 103-109 (2011)
institution	DOAJ
collection	DOAJ
language	EN RU
topic	diabetic foot syndrome pharmacoeconomic analysis modern therapeutic standards pentoxifylline Nutritional diseases. Deficiency diseases RC620-627
spellingShingle	diabetic foot syndrome pharmacoeconomic analysis modern therapeutic standards pentoxifylline Nutritional diseases. Deficiency diseases RC620-627 Marina Fedorovna Kalashnikova Nadezhda Viktorovna Maksimova Ivan Ivanovich Dedov Pharmacoeconomic analysis of conservative strategy for the treatment of patients with diabetic foot syndrome in Moscow
description	Aim. To perform cost-effectiveness analysis of prescription of pharmaceutical products and dressing materials and their consumption volume for inandout-patient treatment of diabetic foot syndrome (DFS). To analyse efficacy of the treatment in terms of modern therapeutic standards. Materials and methods. This retrospective study is based on the medical documentation of 139 DM1 and DM2 patients with DFS from differentmedical facilities of Moscow (2007). 72 patients were given general out-patient care by surgeons of city polyclinics, 50 ones received specialized aidin the regional Diabetic Foot Cabinet. 67 patients were hospitalized: 20 for general care in the department of purulent surgery of a military hospital,27 for specialized care in the department of purulent surgery of a city hospital, 20 for high-technology care in the endocrinological clinic of the FirstMoscow State Medical University. Results. Therapeutic strategy for DFS patients used in the regional Diabetic Foot Cabinet met the current therapeutic standards. General out-patientcare by surgeons of city polyclinics was at variance with the algorithms adopted in this country. Pharmacoeconomic analysis of the spectrum of pharmaceuticalproducts used for in- and out-patient treatment of DFS patients revealed frequent and ungrounded application of drugs whose woundhealing effect remains to be confirmed (pentoxifylline, thioctoic and alpha-lipoic acids). Conclusion. Additional training courses for surgeons of Moscow polyclinics are needed to improve the quality of medical aid to DFS patients. Suchpatients must be referred to regional Diabetic Foot Cabinets. Pentoxifylline, thioctoic and alpha-lipoic acids need to be substituted by pharmaceuticalswith validated therapeutic efficacy.
format	article
author	Marina Fedorovna Kalashnikova Nadezhda Viktorovna Maksimova Ivan Ivanovich Dedov
author_facet	Marina Fedorovna Kalashnikova Nadezhda Viktorovna Maksimova Ivan Ivanovich Dedov
author_sort	Marina Fedorovna Kalashnikova
title	Pharmacoeconomic analysis of conservative strategy for the treatment of patients with diabetic foot syndrome in Moscow
title_short	Pharmacoeconomic analysis of conservative strategy for the treatment of patients with diabetic foot syndrome in Moscow
title_full	Pharmacoeconomic analysis of conservative strategy for the treatment of patients with diabetic foot syndrome in Moscow
title_fullStr	Pharmacoeconomic analysis of conservative strategy for the treatment of patients with diabetic foot syndrome in Moscow
title_full_unstemmed	Pharmacoeconomic analysis of conservative strategy for the treatment of patients with diabetic foot syndrome in Moscow
title_sort	pharmacoeconomic analysis of conservative strategy for the treatment of patients with diabetic foot syndrome in moscow
publisher	Endocrinology Research Centre
publishDate	2011
url	https://doaj.org/article/16c8a85b71f9412a80940ad61ddf61fd
work_keys_str_mv	AT marinafedorovnakalashnikova pharmacoeconomicanalysisofconservativestrategyforthetreatmentofpatientswithdiabeticfootsyndromeinmoscow AT nadezhdaviktorovnamaksimova pharmacoeconomicanalysisofconservativestrategyforthetreatmentofpatientswithdiabeticfootsyndromeinmoscow AT ivanivanovichdedov pharmacoeconomicanalysisofconservativestrategyforthetreatmentofpatientswithdiabeticfootsyndromeinmoscow
_version_	1718429572196728832

Pharmacoeconomic analysis of conservative strategy for the treatment of patients with diabetic foot syndrome in Moscow

Ejemplares similares